Tissue stiffness in FD/MAS patients activates TRPV4 and increases M1 macrophage infiltration, and TRPV1 has a prominent role with TRPV4 in external stimuli and inflammatory environmental episodes; thus, this ion channel is considered a potential therapeutic target for FD/MAS pain. Here, TRPV1 is linked to Fabry disease.